Speciality chemicals manufacturer eyes revenue growth of 20-25 percent in FY15, says CMD Pravin Herlekar, adding that the company will maintain profit after tax (PAT) margins of 7-8 percent in this fiscal, which will improve in FY16.
Omkar Speciality Chemicals Ltd has been granted process patent for an advance intermediate namely "5-IODO-2-METHYLBENZOIC ACID."
Speciality chemicals manufacturer eyes revenue growth of 20-25 percent in FY15, says CMD Pravin Herlekar, adding that the company will maintain profit after tax (PAT) margins of 7-8 percent in this fiscal, which will improve in FY16.
Transcript to follow shortly
Omkar Special stock price
On September 17, 2014, at 14:32 hrs Omkar Speciality Chemicals was quoting at Rs 147.10, up Rs 0.15, or 0.10 percent. The 52-week high of the share was Rs 161.00 and the 52-week low was Rs 68.70.
The company's trailing 12-month (TTM) EPS was at Rs 6.87 per share as per the quarter ended June 2014. The stock's price-to-earnings (P/E) ratio was 21.41. The latest book value of the company is Rs 65.76 per share. At current value, the price-to-book value of the company is 2.24.
Anda sedang membaca artikel tentang
Omkar Speciality Chemicals eyes 20-25% rev growth in FY15
Dengan url
http://sehatgayahidup.blogspot.com/2014/09/omkar-speciality-chemicals-eyes-20-25.html?m=0
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Omkar Speciality Chemicals eyes 20-25% rev growth in FY15
namun jangan lupa untuk meletakkan link
Omkar Speciality Chemicals eyes 20-25% rev growth in FY15
sebagai sumbernya
0 komentar:
Posting Komentar